ArticleProceedings of the National Academy of Sciences of the United States of America2025
Dimerization-activated PP2C-D2 and D5 phosphatases negatively regulate brassinosteroid signaling by antagonizing BRI1.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Brassinosteroids (BRs) are key hormones that promote plant growth and development. While reversible phosphorylation of the BR receptor BRASSINOSTEROID-INSENSITIVE 1 (BRI1) is critical for BR signaling, much remains to be learned about the dephosphorylation mechanisms of BRI1. Here, we demonstrate that the D-clade type 2C protein phosphatases (PP2C-Ds) negatively regulate BR signaling by dephosphorylating key residues in the kinase activation loop of BRI1. The phosphatase activity of PP2C-D2 and D5 is activated through homo- or heterodimerization, a process antagonized by BR-induced BRI1 phosphorylation or SMALL AUXIN UP RNA15 (SAUR15) binding. BL treatment, BRI1-mediated phosphorylation, or SAUR15 binding disrupts dimerization, returning PPC2C-Ds to a monomeric, inactive state. These data not only reveal another phosphorylation/dephosphorylation cascade regulating BR signaling but also decode unrecognized regulatory mechanisms of PP2C-Ds in plants.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.